Found 19 matching trials
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma PHASE2 This experiment will test the safety and effectiveness of a treatment for m...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma PHASE2 This randomized pilot phase II trial studies how well vaccine therapy works...
Show More Location
Providence Portland Medical Center
Learn More & Join Trial
Melanoma Vaccine With Peptides and Leuprolide PHASE2 The goal of this clinical research study is to learn if the drug leuprolide...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
National Cancer Institute Surgery Branch
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Learn More & Join Trial
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity EARLY_PHASE1 This is a pilot trial to investigate the use of GM-CSF DNA as an adjuvant f...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma PHASE1 RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in differe...
Show More Location
Providence Cancer Center at Providence Portland Medical Center
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Show More Location
USC/Norris Comprehensive Cancer Center and Hospital
Learn More & Join Trial
Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients PHASE1 This phase I/II study is directed at evaluating safety and immunogenicity o...
Show More Location
University Hospital Tor Vergata
Learn More & Join Trial
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma PHASE2 This study will examine the effectiveness and side effects of an experiment...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial